|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.79 USD | +6.93% |
|
+5.33% | -19.64% |
| 06-28 | AtriCure, Inc.(NasdaqGM:ATRC) added to Russell 2000 Defensive Index | CI |
| 06-28 | AtriCure, Inc.(NasdaqGM:ATRC) added to Russell 2000 Growth-Defensive Index | CI |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 1,610 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | -18.15% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 1,454 | 1,378 | 1,272 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | -22.37% | -5.25% | -7.65% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 693x | 93.5x | 52.6x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 2.84x | 2.55x | 2.24x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -6x | 0x | 0.7x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 2.66x | 2.37x | 2.11x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 2.4x | 2.03x | 1.67x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 18x | 14.1x | 10.7x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 253x | 65.6x | 33.8x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 26.9x | 33.6x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 3.71% | 2.97% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.0459 | 0.34 | 0.6043 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 605 | 678.5 | 763.4 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 80.76 | 97.38 | 119.1 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 5.738 | 20.99 | 37.67 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 2.66 | 17.48 | 30.62 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -156 | -232.3 | -337.7 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 31.79 | 31.79 | 31.79 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,641 | - | - |
| Announcement Date | 2/15/22 | 2/21/23 | 2/15/24 | 2/12/25 | 2/17/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 693.2x | 2.4x | 18x | - | 1.61B | |
| 23.6x | 3.54x | 13.29x | 2.67% | 166B | |
| 18.86x | 3.29x | 11.59x | 3.56% | 106B | |
| 16.3x | 0.18x | 11.67x | 0.8% | 57.69B | |
| 32.35x | 7.85x | 20.53x | 1.24% | 53.2B | |
| 39.39x | 3.1x | 10.64x | 2.44% | 43.56B | |
| 41.35x | 1.48x | 13.02x | 0.19% | 36.52B | |
| 29.11x | 5.18x | 16.53x | -.--% | 27.49B | |
| 43.44x | 7.53x | 27.19x | 0.24% | 25.84B | |
| 24x | 3.51x | 12.61x | 1.21% | 21.27B | |
| Average | 96.16x | 3.81x | 15.51x | 1.37% | 53.98B | |
| Weighted average by Cap. | 28.46x | 3.65x | 14.08x | 2.01% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
